Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter ...

Short interest in Achieve Life Sciences Inc (NASDAQ:ACHV) increased during the last reporting period, rising from 3.16M to 3.28M. This put 12.49% of the company's publicly available shares short.

Rick Stewart, CEO of Achieve Life Sciences, commented ... small biotech companies launching their first product and offer value-driven, efficient solutions designed to ensure successful ...